Healthcare
Live Price
Offline$202.61
+1.61% today
1Y Change
-13.08%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
STERIS plc (STE) is a Healthcare stock with a market cap of $21.04B and listed on NYSE. The stock last traded around $202.61 and down 13.1% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +6.2%, EPS growth of +62.9%, a dividend yield of 1.1%. What stands out right now is revenue +6.2%, EPS +62.9%, free cash flow +26.9% with operating margin 17.2% and ROIC 7.8%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 29.8 and price/sales 3.6. Stock Foundry combines STE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STE Max Drawdown
-24.87%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STE and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$3.1B
-26.4% YoY
FY Net Income
$397.4M
+62.9% YoY
Free Cash Flow
$450.4M
+13.4% YoY
Revenue Growth
+6.2%
EPS Growth
+62.9%
Gross Margin
44.1%
Net Margin
12.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.5B | 5.1B | 4.5B | 4.2B | 3.1B |
| Gross Profit | 2.4B | 2.2B | 2.0B | 1.9B | 1.3B |
| Operating Income | 867M | 836M | 791M | 478M | 548M |
| EBITDA | 1.4B | 1.4B | 1.3B | 1.0B | 774M |
| Net Income | 615M | 378M | 107M | 244M | 397M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 172M | 207M | 208M | 348M | 221M |
| Total Assets | 10.1B | 11.1B | 10.8B | 11.4B | 6.6B |
| Total Liabilities | 3.5B | 4.7B | 4.7B | 4.9B | 2.7B |
| Shareholder Equity | 6.6B | 6.3B | 6.1B | 6.5B | 3.9B |
| Total Debt | 2.2B | 3.4B | 3.2B | 3.3B | 1.8B |
| Net Debt | 2.0B | 3.2B | 3.0B | 2.9B | 1.6B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
690M
+0.7% YoY
Capital Expenditures
239M
+16.8% YoY
Free Cash Flow
450M
+13.4% YoY
Key ratios
Gross Margin
44.1%
Operating Margin
17.2%
Net Margin
12.1%
ROE
10.2%
Debt / Equity
0.29x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.